In summary, our research provided clinical insights, such as using G-CSF to shorten the duration of neutrophil depletion, thereby avoiding the risk of viral infection in patients, especially for high-risk patients with a low proportion of lymphocytes (<20%). This evidence concerns the gene CSF3 and viral infectious disease.